HealthEquity (NASDAQ:HQY) Trading Down 6.5% – Here’s Why

HealthEquity, Inc. (NASDAQ:HQY) fell 6.5% during trading on Monday . The stock traded as low as $88.01 and last traded at $88.0690. 135,262 shares traded hands during trading, a decline of 84% from the average session volume of 834,084 shares. The stock had previously closed at $94.15.

Analyst Ratings Changes

Several brokerages have weighed in on HQY. Citizens Jmp lifted their price objective on HealthEquity from $117.00 to $122.00 and gave the company a “market outperform” rating in a report on Thursday, December 4th. The Goldman Sachs Group cut HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price target for the company. in a research note on Friday. BTIG Research reissued a “buy” rating and set a $130.00 target price on shares of HealthEquity in a research note on Thursday, December 4th. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a research note on Wednesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $120.00 target price on shares of HealthEquity in a research note on Friday, December 5th. Two analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and an average price target of $119.60.

HealthEquity Price Performance

The business has a 50-day moving average price of $97.04 and a 200 day moving average price of $95.14. The stock has a market cap of $7.22 billion, a PE ratio of 38.79, a PEG ratio of 1.36 and a beta of 0.20. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. The business had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The firm’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, research analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Delano Ladd sold 1,500 shares of the stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $94.72, for a total transaction of $142,080.00. Following the transaction, the executive vice president directly owned 73,979 shares in the company, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the sale, the executive vice president owned 45,742 shares of the company’s stock, valued at $4,366,073.90. The trade was a 19.33% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 15,459 shares of company stock worth $1,483,062 in the last three months. Insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Norges Bank bought a new position in HealthEquity in the 2nd quarter worth $75,072,000. Westfield Capital Management Co. LP boosted its holdings in shares of HealthEquity by 124.6% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after buying an additional 701,819 shares in the last quarter. AQR Capital Management LLC increased its stake in shares of HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after acquiring an additional 661,795 shares in the last quarter. Woodline Partners LP purchased a new stake in shares of HealthEquity in the third quarter worth $26,193,000. Finally, Vanguard Group Inc. increased its holdings in shares of HealthEquity by 2.9% in the 3rd quarter. Vanguard Group Inc. now owns 8,746,255 shares of the company’s stock worth $828,883,000 after purchasing an additional 243,549 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.